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Aim To apply massively parallel and clonal sequencing 
(next generation sequencing or NGS) to the analysis of fo-
rensic mixed samples.
Methods A duplex polymerase chain reaction (PCR) assay 
targeting the mitochondrial DNA (mtDNA) hypervariable 
regions I/II (HVI/HVII) was developed for NGS analysis on 
the Roche 454 GS Junior instrument. Eight sets of multiplex 
identifier-tagged 454 fusion primers were used in a combi-
natorial approach for amplification and deep sequencing 
of up to 64 samples in parallel.
Results This assay was shown to be highly sensitive for 
sequencing limited DNA amounts ( ~ 100 mtDNA copies) 
and analyzing contrived and biological mixtures with low 
level variants ( ~ 1%) as well as “complex” mixtures (≥3 con-
tributors). PCR artifact “hybrid” sequences generated by 
jumping PCR or template switching were observed at a 
low level (<2%) in the analysis of mixed samples but could 
be eliminated by reducing the PCR cycle number.
Conclusion This study demonstrates the power of NGS 
technologies targeting the mtDNA HVI/HVII regions for 
analysis of challenging forensic samples, such as mixtures 
and specimens with limited DNA.
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Limited and mixed DNA samples are often encountered in 
forensic cases and pose both technical and interpretation 
challenges. The highly polymorphic hypervariable regions 
I/II (HVI/II) of the mitochondrial genome are often success-
fully used to analyze limited and/or degraded DNA sam-
ples (1). However, there are some limitations to the current 
standard approaches used for mitochondrial DNA (mtD-
NA) sequence analysis when mixtures are encountered. In 
a five year retrospective study of mtDNA analysis of 691 
casework hair samples, a mixture of mtDNA sequences at-
tributed to a secondary source was observed in 8.7% of the 
hairs and sequence heteroplasmy was observed in 11.7% 
of the cases (2). While approaches that use capillary elec-
trophoresis technologies for Sanger sequencing of mtD-
NA polymorphic regions allow for detection of mixtures, 
they do not allow for resolving individual sequences in a 
mixture (3-10). Mitochondrial DNA markers are ideal tar-
gets for detecting mixtures since, with few exceptions, 
a single sequence per contributor is the expected result 
due to its haploid nature. However, unlike short tandem 
repeats (STRs), peak areas or heights in sequence electro-
pherograms are not necessarily indicative of the amount 
of DNA contributed to a mixture (9,11,12). As a result, 
peak height ratios for two bases cannot be used to deter-
mine the relative proportions of components of a mixture 
for mtDNA Sanger sequencing analysis. For this reason, 
Sanger sequencing does not allow for determining the in-
dividual mtDNA sequence haplotypes of mixed samples. 
Therefore, when mixed base calls are encountered during 
mtDNA Sanger sequence analysis of forensic specimens, 
most forensic laboratories choose not to interpret the re-
sult and categorize mtDNA mixture results as inconclusive 
for reporting purposes (13). Furthermore, Sanger sequenc-
ing cannot detect minor components present at less than 
10% in a DNA mixture (9,12).
The 454 genome sequencing technology is a scalable, 
clonal, and highly parallel pyrosequencing system that can 
be used for de novo sequencing of small whole genomes 
or direct sequencing of DNA products generated by poly-
merase chain reaction (PCR). The technology uses emul-
sion PCR (emPCR) to amplify a single DNA sequence to 10 
million identical copies. The “clonal sequencing” aspect of 
the technology enables separation of individual compo-
nents of a mixture as well as analysis of highly degraded 
DNA. The clonal sequencing approach used with the 454 
GS technology and other next-generation sequencing 
(NGS) technologies provides a digital readout of the num-
ber of reads or individual sequences allowing for a quanti-
tative determination of the components in a mixture (14). 
Recently, the potential value of using NGS technologies for 
forensic applications has been demonstrated (15-18). This 
article aims to describe a highly sensitive NGS method that 
uses PCR for targeted enrichment of the HVI/HVII regions 
of mtDNA for resolving simple and complex mixtures as 
well as detecting low levels of heteroplasmy.
MAtEriAls AnD MEtHoDs
The study was conducted between September 2012 and 
January 2014 at Children’s Hospital Oakland Research In-
stitute, Genetics Department, and was approved by the 
Children’s Hospital & Research Center Oakland Institutional 
Review Board.
454 library preparation: HVi/HVii PCr targeted 
enrichment
The highly polymorphic HVI and HVII regions of the mi-
tochondrial genome were enriched from genomic DNA 
samples using a duplex PCR. Mitochondrial DNA HVI/HVII 
duplex primer sequences described previously in Gabriel 
et al (19) were modified to incorporate the 454 sequenc-
ing primer, library key, and unique multiplex identifier 
(MID) sequence necessary for subsequent emPCR, pyrose-
quencing, and sample identification during the data analy-
sis. Each sample was amplified using a unique MID-tagged 
454 HVI/HVII fusion primer set. A set of HVI/HVII fusion 
primer sequences with MID tag 1 are shown in the Figure 
1. Unique 10 base MID tags are used as sample identifiers 
in order to pool and sequence multiple samples in a single 
454 sequencing run with each sample being “tagged” or 
“barcoded” with a different MID tag. The eight sets of MID 
tags used for the fusion primer sets are provided in Supple-
mentary Table 1. The eight sets of MID-tagged fusion prim-
ers were designed to be used in a combinatorial approach 
to generate 64 different combinations of forward and re-
verse MID-tagged HVI/HVII PCR products (Supplementary 
Figure 1). This combinatorial approach was utilized in order 
to reduce the number of PCR primers required.
Each sample was amplified in a 50 µL PCR reaction contain-
ing 1.2X GeneAmp® PCR Buffer II without MgCl2 (Life Tech-
nologies, Foster City, CA, USA), 2.4 mM MgCl
2, 0.2 mM each 
dNTP (Roche Life Sciences, Indianapolis, IN, USA), 0.25 U/µL 
EagleTaq DNA Polymerase (Roche Custom Biotech, India-
napolis, IN, USA), and 0.3 µM each primer. Both HVI (15975-
16501) and HVII (15-410) regions were amplified in a sin-
gle tube using a set of MID-tagged fusion primers. All 
reactions were performed in GeneAmp® PCR Systems 
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9600 thermal cycler (Applied Biosystems, Carlsbad, CA, USA) 
using the following cycling conditions: a 14-minute 94°C ac-
tivation cycle; 34 cycles of amplification at 94°C for 15 sec-
onds, 65°C for 30 seconds, and 72°C for 30 seconds; and a 
final 10-minute 72°C extension cycle. PCR products were 
analyzed on 1.5% agarose gels in 1X Tris-Acetate-EDTA elec-
trophoresis buffer (TAE) stained with 0.5 µg/mL ethidium 
bromide to confirm successful amplification of the target re-
gions and to assess primer dimer and PCR specificity.
454 library preparation: PCr product quantification and 
small fragment removal
Each PCR product was quantified using Quant-iT PicoGreen® 
dsDNA Assay kit (Life Technologies) to determine the DNA 
amount in copy number for sample normalization and sub-
sequent library pooling. An approximately equal copy num-
ber of each amplified sample was combined into a single 
library pool. Small fragment DNA or primer dimers were re-
moved from the pooled library using Agencourt AMPure XP 
(Beckman Coulter Inc., Pasadena, CA, USA) with 1:1 AMPure 
to DNA sample volumetric ratio. The Agilent DNA 1000 kit 
(Agilent Technologies, Santa Clara, CA, USA) was used fol-
lowing manufacturer’s protocol in order to compare the li-
brary pool before and after AMPure purification to confirm 
the removal of primer dimers. The concentration of the pu-
rified library pool was estimated using Quant-iT PicoGreen® 
dsDNA kit (Life Technologies) or Library Quantification Kit 
- 454 FLX (Kapa Biosystems, Wilmington, MA, USA) to esti-
mate the DNA copy number of the library pool.
tAblE 1. number of sequence reads obtained from varying DnA input amounts
number of 454 reads
Hypervariable region i Hypervariable region ii
DnA amount mtDnA copy number forward reverse total forward reverse total
1 ng  ~ 1 000 000 56 116 172 189 110 299
500 pg 500000 43 103 146 174 94 268
100 pg 100000 61 122 183 161 97 258
50 pg 50000 63 145 208 177 105 282
10 pg 10000 56 88 144 130 105 235
5 pg 5000 91 156 247 138 121 259
1 pg 1000 56 130 186 104 78 182
0.5 pg 500 80 131 211 195 115 310
0.1 pg 100 19 37 56 66 45 111
0.05 pg 50 24 48 72 59 52 111
0.01 pg 10 0 5 5 5 0 5
0.005 pg 5 0 4 4 4 0 4
0.001 pg 1 3 0 3 6 4 10
FigurE 1. Hypervariable region i/ii (HVi/ii) i forward and reverse fusion primers. A total of four primers comprised of a duplex primer 
set targeting HVi and HVii. Each primer consists of the 454 Adaptor sequence (bold), library Key sequence (italics), multiplex identi-
fier (MiD)-tag sequence (gray), and the forward or reverse HVi/HVii locus specific primer sequence (19). the numbering used for the 
primer names corresponds to the revised Cambridge reference sequence (rCrs) (20). the MiD sequences (grey) are tagged with 
published MiD sequences 1 through 8 to create eight sets of primers per targeted region (supplementary Figure 1).
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454 emulsion PCr and ngs using the gs Jr
The quantified and purified library pool was then diluted 
with modified TE-4 (10 mM Tris, 0.1 mM EDTA, pH 8.0) to 
the concentration of 4 × 105 molecules/uL in order to add 
a total of 10 uL to achieve a 0.4:1 DNA to bead ratio in emP-
CR. The optimal DNA to bead ratio was determined to be 
0.4:1 based on the number of high quality pass filter reads. 
Targeting the optimal DNA:bead ratio is critical to avoid the 
incorporation of more than one molecule of DNA per bead 
or insufficient bead recovery. The finalized library pool was 
amplified using the GS Junior Titanium emPCR Kit (Lib-A) 
(Roche Life Sciences) following the manufacturer’s proto-
col. All successfully prepared libraries were sequenced on 
the 454 GS Junior System (454 Life Sciences, Branfod, CT, 
USA). Amplicon Variant Analyzer (AVA) was used to analyze 
the 454 sequence data and identify SNP variants compared 
to the revised Cambridge sequence (rCRS) (20).
sample preparation and experimental designs: 
sensitivity
Sensitivity and concordance studies. A sensitivity study 
was conducted to determine the limits of the assay as fol-
lows. The mtDNA copy number and nDNA concentration 
of a control DNA sample K562 High Molecular Weight, 
(Promega, Madison, WI, USA) was quantified using a mt:nu 
qPCR assay and serially diluted (21). Thirteen dilutions vary-
ing in starting mtDNA copy number (1 000 000 to 1 mtD-
NA copy) and nDNA input amount (1 ng to 0.001 pg) were 
amplified (Table 1). The 13 libraries were then normalized 
for amplicon copy number estimated using the Qubit® 
dsDNA HS Assay Kit (Life Technologies), combined into 
a single library pool, and sequenced using the 454 GS Jr. 
To determine the accuracy of the assay, 454 HVI/HVII se-
quence data were generated and analyzed from previously 
collected blood derived DNA samples from four popula-
tion groups (45 African American, 43 Caucasian, 40 Hispan-
ic, and 45 Japanese) (22). Sanger sequencing results were 
available for comparison to the 454 NGS data (23).
Contrived and biological mixture studies. Mixture studies 
(two and three person mixtures) were conducted to deter-
mine the sensitivity of the assay for detecting and resolv-
ing the minor sequences in a mixed specimen. Two Coriell 
Cell line DNA samples (Coriell Institute, Camden, NJ, USA), 
differing at 10 base positions (7 in HVII and 3 in HVI) de-
termined previously using Sanger sequencing were mixed 
together at various ratios based on the mtDNA copy num-
ber. The mtDNA copy number was determined using a 
mt:nu qPCR assay described by Timken et al (21). The two 
DNA samples were mixed at the following ratios and were 
then amplified using the 454 HVI/HVII NGS PCR assay and 
sequenced using the 454 GS Jr: 100:0, 99.9:0.1, 99.75:0.25, 
99.5:0.5, 99:1, 97.5:2.5, 95:5, 90:10, 75:25, 50:50, 25:75, 10:90, 
5:95, 2.5, 97.5, 1:99, 0.5:99.5, 0.25:99.75, 0.1:99.9, and 0:100. 
A complex mixture sample was prepared by combining 
DNA based on the mtDNA copy number of three individ-
uals and the HVI/HVII amplicon library was prepared fol-
lowing the above described method and sequenced us-
ing the 454 GS Jr. instrument. To study the effect of cycle 
number on generation of jumping PCR hybrids with the 
454 HVI/HVII NGS assay, a 50:50 mixture of two Coriell Cell 
line DNA samples (Coriell Institute), was amplified at vary-
ing cycle numbers ranging from 34 to 24 cycles in 2 cycle 
increments. DNA from a buccal swab, blood, and five hairs 
from a monozygotic twin pair previously identified as het-
eroplasmic in at least one tissue was analyzed using the 
HVI/HVII NGS assay. DNA libraries were prepared by ampli-
fying ~ 100 pg DNA from each sample and sequenced us-
ing the 454 HVI/HVII NGS assay (24,25). The HV+ 5plex and 
10plex typing results for these samples were available for 
comparison (unpublished data).
rEsults
sensitivity and reproducibility of the assay
A sensitivity study was conducted to determine the min-
imum starting DNA amount of the 454 HVI/HVII NGS as-
say as well as to explore the stochastic effects in the PCR 
amplification step of the assay. The HVI/HVII 454 sequenc-
ing assay was shown to be highly sensitive for limited in-
put of genomic DNA. Amplification and sequencing was 
successful for samples with DNA amounts as low as ~ 1 pg 
genomic DNA or 100-500 mtDNA copies (Table 1). DNA 
amounts ranging from 0.5 pg-1 ng resulted in an average 
of 261 combined reads, ranging from 182-310 reads (Ta-
ble 1). The number of reads decreased 2-fold with samples 
amplified with 0.1 pg and 0.05 pg of input DNA relative to 
higher input amounts. Also, DNA starting amounts lower 
than 0.05 pg resulted in an extremely low number of reads, 
often unidirectional (Table 1). Based on these results, the 
assay sensitivity was determined to be 0.5 pg or ~ 500 cop-
ies. However, the limit of starting DNA amount of the assay 
could potentially be lowered to 0.1 pg or 0.05 pg by elimi-
nation of the dilution process after the amplification of 
the low copy number samples along with increasing the 
amount of PCR product added for the sequencing for 
those specific samples. This sensitivity study dem-
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onstrated that NGS results can be obtained from lower 
amounts of DNA than previously reported or recommend-
ed by the manufacturer (pg amounts compared to ng or 
µg amounts). Also, the assay was very specific and did not 
produce any fragment reads outside of the targeted HVI/
HVII regions or short fragments (primer dimer) (Figure 2). 
Only reads corresponding to the sizes of the HVI and HVII 
amplicons were observed.
Concordance study on population samples
The sequence data of population samples produced from 
the 454 HVI/HVII NGS assay were concordant with Sanger 
sequencing results for the HVI and HVII regions outside of 
homopolymer C stretch regions (positions 16180-16195 and 
286-315, respectively). The sequences generated by the 454 
HVI/HVII NGS assay showed concordance with the Sanger 
sequencing results at all base substitution positions (point 
mutations) when a 10% threshold was applied to the data 
analyzed using the 454 AVA software. A 10% threshold was 
applied to account for the lower sensitivity of Sanger se-
quencing for minor base detection (10%-15%) compared 
to 454 sequencing (1%-3%). Minor base differences were 
observed at some base positions at levels below the 10% 
threshold with 454 sequencing. These minor base differenc-
es observed at very low frequency (<1%) can be attributed 
to PCR or sequencing error or heteroplasmy; further analysis 
is needed in order to distinguish true signal from noise.
As expected, 454 pyro-sequencing errors were observed 
as insertion/deletions (IN/DEL) above the 10% threshold 
within the sequence surrounding the two homopolymer 
C stretches in the HVI/HVII regions, which resulted in se-
quence alignment errors using the AVA software. Typically, 
these IN/DEL sequencing errors were observed in only a 
single direction and/or the base calls for a given position 
were imbalanced. Specifically, pyro-sequencing errors and/
or length heteroplasmy in the HVI region spanning base 
positions 16180-16195 (5’-AAAACCCCCTCCCCAT-3’) result-
ed in alignment issues using the AVA software. An A/C mu-
tation at position 16183 and any C/T transition observed 
between base positions 16184 to 16193 of this region was 
reported as a combination of IN/DEL of A/C or C/T, with im-
balanced frequencies between read directions. The SNPs 
in the homopolymer region were detected, but were not 
reported correctly due to alignment issues from homopo-
lymer pyro-sequencing errors or potentially length hetero-
plasmy using the 454 AVA software.
Additionally, pyro-sequencing errors and/or length hetero-
plasmy within the homopolymer region surrounding the 
C-stretch in the HVII region spanning positions 286- 315 
(5’-AAAAAATTTCCACCAAACCCCCCCTCCCCC-3’) were ob-
served. Within this region, an A deletion was sometimes 
reported at base position 291, and position 295 was re-
ported as a mixture of C/T followed by C deletion both 
with directionally imbalanced frequencies using 454 AVA 
FigurE 2. Distribution of reads for 454 HVi/HVii ngs Assay. the read length distribution of a 454 hypervariable region i/ii (HVi/HVii) 
sequencing run reported by gs run browser software (454 life sciences, bradford, Ct, usA). the shorter peak of 450 bp corresponds 
to the HVii library amplicons (415 bp HVii region) and the 475 bp product to amplified HVi libraries (444 bp HVi region). the absence 
of any peak below 430 bp indicates the effective removal of primer dimers.
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software. These observations can be partially explained as 
a sequence alignment issue for the specific regions with 
homopolymers within the HVI/HVII sequences using the 
454 sequencing platform as it is well established that pyro-
sequencing has a relatively high error rate in homopoly-
mer regions (26).
Quantitative analysis of mixture sequences and PCr 
artifacts
We conducted a two person mixture study to determine the 
sensitivity of the 454 HVI/HVII NGS assay for detecting minor 
components in a mixture. 454 HVI/HVII sequencing results 
are presented in Table 2 for a subset of the mixture ratios. 
The minor and major sequences were detected using 454 
NGS sequencing at all mixed based positions for samples 
mixed at a 2.5% ratio and above. For the 1% mixture ratio 
with COR110 as the minor sequence, the minor base was 
detected for all mixed based positions except position 150 
in the HVII region with a 370 read depth. For the 1% mix-
ture ratio with COR073 as the minor sequence, the minor 
bases at all mixed base positions were not detected in HVII 
but were in HVI. However, only 274 reads were obtained for 
the HVII region (average 1.7 reads per base for the minor se-
quence) compared to 516 reads for HVI region (average 3.0 
reads per base for the minor sequence) for this sample. The 
minor contributor sequence in a 1% mixture would not be 
expected to be reliably detected with such low read cover-
age of 1-3 reads for the minor contributor sequence with 
a low depth of coverage (250-500). To reliably detect the 
minor sequence in a 1% mixture, greater than 1000 read 
coverage would be needed. An approximately 20%-40% 
difference from the expected mixture ratio was observed 
in each experimental mixture sample, with the number of 
reads for one sample in the mixture (COR110) consistently 
being under-represented. Based on these results, the mt:nu 
qPCR most likely overestimated the mtDNA copy number 
of C110 and thus the actual mixture ratio could have been 
skewed from the expected mixture ratio. These results show 
that NGS is a highly sensitive method for detecting minor 
components in a mixture (2.5% compared to 10%-15% for 
Sanger sequencing) and quantitative as a digital read-out 
can be reported by counting the number of sequence reads 
corresponding to the individual components.
FigurE 3. Hypervariable region ii (HVii) region sequencing results obtained from a mixture sample composed of three contributors. 
three samples differing at multiple base positions were combined (67.8%, 21.7%, and 10.5%) based on mtDnA copy number prior 
to HVi/HVii amplification. the frequency of the observed sequence reads for the 454 HVii amplicon is reported as determined using 
the Amplicon Variant Analyzer software (454 life sciences, bradford, Ct, usA). reads for the HVi and HVii amplicon corresponding to 
each of the three contributors were observed (results for HVii presented). Further, 6 chimeric sequences were detected, each occur-
ring at low frequency (<2%).
tAblE 2. Minor base frequency in two person mixture
Hypervariable region ii Hypervariable region i
Expected observed base frequency (%) no. of observed base frequency (%) no. of
frequency (%) 94 150 152 189 194 200 228 reads 16093 16327 16362 reads
25 17.1 17.1 18.1 18.1 17.31 17.31 17.31 387 20.5 21.51 22.35 595
10 7.44 6.15 6.8 6.8 6.8 6.8 6.8 309 9.16 8.42 8.42 546
5 1.8 1.8 1.8 1.8 1.8 2.31 1.8 389 4.9 5.92 4.69 490
2.5 1.67 1.67 1.67 1.67 1.67 1.67 1.67 418 2.51 2.51 2.51 479
1 0.54 0 0.54 0.54 0.54 0.54 0.54 370 0.59 0.59 0.59 505
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Complex mixtures and jumping PCr
A complex mixture study (≥3 contributors) was conduct-
ed to test the 454 HVI/HVII assay’s capability to detect 
and resolve multiple sequences in a mixed sample. 454 
HVII NGS results for a three person mixture are presented 
in Figure 3. Using the 454 HVI/HVII NGS assay, we were 
able to detect and resolve each of the three contributor 
sequences in a complex mixture. The three contributors’ 
distinct sequences were resolved from a mixture sample, 
and showed concordance with the Sanger sequencing 
results at all base substitution positions excluding the 
homopolymer C-stretch region in HVII (Figure 3). Further, 
evidence of jumping PCR (in vitro crossover artifact) was 
observed in each of the complex mixtures as chimeric or 
hybrid sequences were present at low levels (Figure 3). 
A total of six hybrid HVII sequences were observed rang-
ing from 0.4 to 2% for the three person complex mixture 
sample.
Jumping PCR, a phenomenon where a single strand of 
DNA partially extended on one template can act as a 
primer on the other template to generate an amplicon 
with chimeric sequences, can occur during late PCR cy-
cles when the number of amplicon copies is very high and 
the concentration of primers and enzyme is low (27). As 
expected, an increase in the number and the frequency 
of chimeric sequences resulting from jumping PCR events 
was observed with each increase in cycle number from 24 
to 34 cycles (Figure 4). The 50:50 mixed sample amplified 
with 34 cycles resulted in 10 different chimeric sequences 
with a total frequency of 15.41%. At 24 cycles, one chi-
meric sequence was detected with a frequency of 0.62% 
(Figure 4). Chimeric sequences generated from jumping 
PCR events in mixed samples could be problematic for 
the forensic application of NGS if they are observed at a 
high frequency and are not properly recognized. Further 
improvements to NGS software to include filters to flag or 
remove jumping PCR chimeras should be considered to 
aid with mixture analysis.
biological mixture sequence application: heteroplasmy
To further determine the detection limits of the 454 HVI/
HVII NGS assay, a heteroplasmy study was conducted. 
HV+ HaploArray (HaploID Genetics, Alameda, CA, USA) 
and 454 HVI/HVII NGS results from five hairs, blood, and 
buccal samples from one twin pair with heteroplasmy at 
position 16093 are presented in Figure 5. HV+ HaploAr-
ray analysis detected a mixture of bases (T/C) at position 
16093 for hair samples 1,3,4, and 5, observed as two posi-
tive probe signals for 16093 (1/2). While relative propor-
tions of the T/C bases can be estimated by the intensity 
of the probe signal, an observed frequency for each base 
FigurE 4. Characterization and reduction of jumping polymerase chain reaction (PCr) artifacts observed in 454 sequencing data. two 
different samples (A and b) differing at 15 positions in the hypervariable region ii (HVii) were mixed at equimolar mtDnA copies prior 
to HVi/HVii PCr and amplified at varying cycle numbers – 24,26,28,30,32,34. HVii sequence results obtained using the 454 gs Jr from a 
sample amplified with 34 cycles and 24 cycles are presented. the number of chimeric sequences (10 sequences) with 34 cycles of ampli-
fication decreased to one chimeric sequence when the amplification cycle number was reduced to 24 cycles. Additionally, the observed 
frequency of chimeric sequences decreased dramatically from 13.18% to 0.62% when the cycle number was reduced.
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FigurE 5. Comparison of methods for detection and quantification of 
heteroplasmy. Panel A shows the HV+ 5 plex immobilized sequence-spe-
cific oligonucleotide probe typing data and Panel b shows the percent 
reads observed by 454 ngs for each base (t or C) at the heteroplasmic 
position 16093 for five hair samples, a buccal, and a blood sample 
from one individual heteroplasmic at a hot spot position 16093 in the 
hypervariable region i (HVi) region. A single signal corresponding to a C 
at position 16093 was observed for the blood, buccal, and one of the five 
hair samples (Hair 2) using the HV+ 5 plex probe panel; heteroplasmy 
was detected at position 16093 in all samples using the more sensitive 
454 ngs technology (average of 750 read depth per sample).
can be determined for the NGS analysis (Figure 5). The 454 
NGS analysis was also more sensitive for the detection of 
heteroplasmy. NGS detected a mixture of T/C at position 
16093 for hair sample 2, blood, and buccal DNA, whereas 
HV+ HaploArray analysis detected only a C at 16093 (ob-
served as a positive 16093 2 probe signal). The observed 
frequency of the T base at position 16093 in hair sample 
2, buccal, and blood (4.9%, 7.0%, and 3.6%, respectively) 
was also below the detection limits of Sanger sequencing 
(typically 10%-15%).
DisCussion
We developed a duplex PCR assay targeting the mtDNA 
(HVI/HVII) using eight sets of 454 MID-tagged fusion prim-
ers in a combinatorial approach for deep sequencing 64 
samples in parallel on a 454 GS Jr. Compared with Sanger 
sequencing of the same samples, the sequence concor-
dance was 100% outside of the homopolymeric regions in 
HVI and HVII using a 10% cut-off for the 454 sequencing 
data. Sequencing errors appearing as IN/DEL mutations in 
homopolymer regions were observed. This issue is a well 
known feature of NGS based on pyrosequencing (28). Re-
cent publications using the 454 GS Junior and the Ion Tor-
rent PGM instrument, which detects the release of protons 
rather than pyrophosphate, as in the 454 system, also re-
ported difficulties in sequencing the homopolymeric re-
gions of mtDNA HVI/II (29,30). Since an imbalance in the 
frequency of the IN/DEL errors was observed between the 
forward and reverse reads, filters can be applied using soft-
ware tools, such as NextGene software (SoftGenetics, State 
College, PA, USA), to identify these sequencing errors in the 
bioinformatic analysis.
Our assay was shown to be highly sensitive for sequencing 
limited DNA amounts ( ~ 100 mtDNA copies) and detect-
ing mixtures with low level variants ( ~ 1%) as well as “com-
plex” mixtures (≥3 contributors) not possible to analyze by 
Sanger sequencing. The minor base was reliably detected 
at each of the mixed base positions and the observed fre-
quencies were similar to the expected frequencies using 
454 sequencing with ~ 600-1000 reads per amplicon. Fur-
ther, we characterized jumping PCR and resulting hybrid 
artifact sequences that can arise in amplification of mixed 
samples and noted that the frequency of the phenome-
non was template amount- and cycle-dependent. This ef-
fect, which occurs at late cycles of PCR, can be decreased 
by simply lowering the amplification cycle number. In ad-
dition, such chimeric PCR artifacts can be potentially fil-
tered through bioinformatics tools.
The clonal nature of NGS provides a powerful and quan-
titative means of deconvoluting mixtures, a particular-
ly challenging category of forensics specimens. Multiple 
contributors to a mixture can be detected by analyzing the 
different clonal sequence reads identified in the sequence 
analysis and their contribution quantified by simply count-
ing the number of sequence reads. This digital analysis is 
much more precise than estimating peak height or area 
for STR markers or analyzing Sanger electropherograms for 
mtDNA sequences. For chromosomal markers, one must 
make assumptions about which alleles in a mixture “go 
together” as a genotype. Many statistical approaches to 
mixture analysis consider all possible genotype combina-
tions and, in some cases, different numbers of contribu-
tors. Mitochondrial DNA, on the other hand, is a particu-
larly useful marker for deconvoluting mixtures because, 
potential heteroplasmy aside, each distinct mtDNA se-
quence corresponds to (at least) one contributor. Statisti-
cal analyses can capture and incorporate the probability 
that one mtDNA sequence could correspond to more 
than one contributor. Sequencing the entire mtDNA 
genome rather than the HVI/II regions reported here 
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will provide additional valuable discrimination power and 
several groups have recently reported NGS analyses using 
long range PCR (29-31). Recently, we have developed a hy-
brid capture method of whole mtDNA genome sequenc-
ing (32). However, software analyses of whole mtDNA ge-
nome sequences from mixed samples remain a challenge. 
In general, NGS analysis of mtDNA, whether of whole ge-
nome or only HVI/II, represents the most robust approach 
to estimating the number of contributors to a mixture and 
resolving the mixed DNA sequences.
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